Fig. 2
The detected bioburden level post-treatment of bacterial biofilms (CRPA-45 and CRPA-47) with variable concentrations of ceftazidime/colistin (a and b) and gentamicin/meropenem combinations (c and d)
Fig. 2 | Annals of Clinical Microbiology and Antimicrobials